# Completeness Review: AIPredictdisease

- **Review date:** 2026-07-20
- **Assessment basis:** Source/configuration inspection plus isolated PostgreSQL migration/seed, startup, login, persisted-session, authenticated-API verification, focused tests, and a production frontend build.

## Classification

**Prototype-demo**

## Verdict

This is a clinical/health prototype/demo. Its 70 source files and visible routes/pages demonstrate concepts, but they do not establish durable, integrated, tested execution of the AIPredictdisease workflow.

## Why it is not complete

- 22 files are explicitly named as gap/backlog surfaces, so page and route counts overstate implemented product capability.
- 18 project-owned files contain direct provider/chat-completion markers; generic model calls are not a substitute for typed domain tools, grounded evidence, deterministic rules, or evaluations.
- 28 files contain mock, sample, placeholder, simulated, or random-data signals, leaving important outcomes disconnected from authoritative systems.
- No explicit schema or migration evidence was found for durable, versioned domain state.
- No recognizable project-owned automated tests were found for the primary workflow.
- No checked-in CI workflow was found to continuously verify builds, tests, migrations, and security checks.
- No environment example/template was found, leaving required configuration and secret boundaries undocumented.

## Needed features

1. Implement the Predictdisease care workflow with validated observations, decisions, ownership, follow-up, and clinician-visible uncertainty.
2. Connect authoritative EHR/FHIR, laboratory/imaging, device, pharmacy, scheduling, or payer systems appropriate to the workflow, with consent and failure handling.
3. Validate clinical accuracy, calibration, contraindications, missing-data behavior, bias, and escalation on versioned representative datasets.
4. Require clinician approval, least-privilege access, consent, immutable audit, retention controls, and a clearly documented non-diagnostic boundary.
5. Replace the generated “Public Health Database Integration Cdc Who Page” gap surface with durable domain state, real integration behavior, explicit failure handling, and acceptance tests.
6. Add contract, integration, authorization, migration, failure-path, and end-to-end tests in CI, plus a documented nondestructive deployment/run path.

## Implementation progress

1. **Implemented locally:** `/api/governed-disease-observations` records consent, versioned clinical and public-health sources, calibrated risk observations, uncertainty/bias review, clinician review, owned follow-up, authorized public-health review, escalation, resolution, and outcomes; it never diagnoses or treats.
2. **Durable typed boundary implemented; external work remains:** EHR/FHIR, laboratory, public-health registry, imaging, scheduling, and secure-messaging adapters are declared fail closed with opaque evidence and idempotent failures; no clinical/public-health system integration is claimed.
3. **Implemented locally where fixture-based:** versioned fixtures measure freshness, missing-data rate, confidence, calibration error, consent, source verification, and bias-slice status and always require clinician review. Clinical datasets, bias/calibration thresholds, outcomes, and qualified validation remain blockers.
4. **Implemented locally:** active tenant membership, subject-prefix scope, clinician/public-health/privacy RBAC, consent provenance, privacy-minimized evidence, dual control, retention, immutable audit, owned follow-up, and null clinical-action output protect consequential decisions.
5. **Implemented locally:** generated public-health database/gap and direct-provider families are quarantined by default; durable registry version/provenance, clinician/public-health review, explicit failure handling, and acceptance tests replace the claimed integration surface.
6. **Implemented locally:** workflow, authorization, fixture, stale/missing/failure, migration, provider, runtime, and nondestructive-launcher tests run in CI; schema bootstrapping and demo seeding are opt-in and forbidden in production, with an additive migration and runbook checked in.

## Risks or launch blockers

- Incorrect or unreviewed output can cause patient harm.
- Health data requires strong privacy, access, retention, and audit controls.
- A weak JWT/session-secret fallback can make authentication forgeable when configuration is absent.
- The root launcher can terminate unrelated processes occupying configured ports.
- The root launcher seeds, creates, migrates, or otherwise mutates database state during startup.
- The root launcher installs dependencies at run time, reducing reproducibility and expanding supply-chain risk.

## Evidence inspected

- `backend/package.json` — inspected project-owned structure or implementation evidence.
- `backend/src/server.js` — inspected project-owned structure or implementation evidence.
- `backend/src/routes/gapFeat_backend_collapses_to_crud_js.js` — inspected project-owned structure or implementation evidence.
- `start.sh` — inspected project-owned structure or implementation evidence.
- `backend/src/db.js` — inspected project-owned structure or implementation evidence.
- `backend/package-lock.json` — inspected project-owned structure or implementation evidence.

## Recommended next action

Treat this as a prototype: prove one narrow clinical/health outcome end to end with real data, durable state, domain validation, and tests before expanding its feature catalog.

## Runtime verification (2026-07-20)

- `start.sh` honored isolated PostgreSQL/API/UI ports `55582/5984/5985`; API-only test startup avoided stale Vite proxy routing, while the normal proxy target now follows `BACKEND_PORT`.
- The new seed command reused the existing schema/bootstrap implementation behind explicit destructive-demo and non-production guards; login, database-backed `/api/auth/me`, and an authenticated API request passed.
- Governance tests passed (8/8), and the Vite production build completed successfully (with its existing large-chunk warning).
